Novel solid forms of the anti-inflammatory drug oxaprozin may lead to a new combined asthma therapy
An exploratory study by A*STAR scientists into novel solid forms of the anti-inflammatory drug oxaprozin may lead to improvements for the asthma drug, salbutamol, and help reduce inflammation of the airways.